What does the company do?
Eli Lilly and Company discovers, develops, manufactures and sells products in one business segment, pharmaceutical products. The Company also has an animal health business segment. It manufactures and distributes its products through owned or leased facilities in the United States, Puerto Rico and 25 other countries. Eli Lilly and Company’s products are sold in approximately 135 countries. The Company also conducts research to find products to treat diseases in animals and to increase the efficiency of animal food production. Its principal products include Neurosciences products, Endocrinology products, Oncology products, Cardiovascular products, Animal health products and Other pharmaceuticals. On August 20, 2008, the Company acquired SGX Pharmaceuticals, Inc. (SGX). On November 24, 2008, the Company acquired ImClone Systems Inc. (ImClone), a biopharmaceutical company focused on advancing oncology care.
How much does the company sell and earn?
Investors need to know how much stuff or services a company sells, and how much of that total it keeps as income (or profit) to grow its business or return to shareholders. The more of each, the better. In general, look for companies that sell and earn more than peers.
- Eli Lilly one-year sales: 21.11 Bil.
Difference from the average for the Drug Manufacturers - Major group: -49.51% - Eli Lilly one-year income: -216.00 Mil.
| Sales & Income (past 12 months) | Company | Industry |
|---|
| Sales | 21.11 Bil | 41.82 Bil | | Income | -216.00 Mil | 7.45 Bil |
How fast is the company growing?
- Eli Lilly one-year sales growth: 4.80%.
Difference from the average for the Drug Manufacturers - Major group: 3.40 pct. pts. - Eli Lilly one-year income growth: 119.20%.
Difference from the average for the Drug Manufacturers - Major group: 113.90 pct. pts.| Sales & Income Growth (past 12 months) | Company | Industry |
|---|
| Sales Growth | 4.80% | 1.40% | | Income Growth | 119.20% | 5.30% |
How profitable is the company?
Investors prefer companies that increase profit margins -- the percentage of sales that they keep -- every year. This is accomplished either by lowering expenses or raising prices. Look for companies that consistently find ways to squeeze more profits out of sales than their peers.
- Eli Lilly one-year net profit margin: -1.0%
| Net profit margins (%) |
|---|
| Company | -1.0% | | Company 5-Yr Avg. | 8.8% | | Industry | 18.6% |
How is the company's financial health?
The debt/equity ratio shows how much a firm has borrowed as a percentage of its stock equity. The lower, the better.
- Eli Lilly debt/equity ratio: 0.75.
Difference from the average for the Drug Manufacturers - Major group: -67.11%.
| | Company | Industry |
|---|
| Debt/equity ratio | 0.75 | 2.28 |
|
Recent News